For months, high-yielding bond market alternative stocks have been crushed, especially the real estate investment trusts (REITs). However, Cramer pointed to CBRE Group as one real estate investment play that makes investors not have to worry about bond market competition, because it's not a REIT and doesn't pay a dividend.
CBRE is the leading purveyor of commercial real estate services, and also owns properties. It gets approximately three-quarters of its revenue from fee-based businesses, such as providing outsourced leasing, sales, appraisal, development and property management services.
Cramer spoke with CBRE Group's CEO Bob Sulentic, who outlined what a Trump presidency could mean for the company and real estate industry.
"If tax rates go down, that's a good thing. We are a taxpayer, and so that will stimulate not only our company but other companies. If infrastructure spending goes up, that could be a very good thing for our sector," Sulentic said.
After hearing positive news from Bluebird Bio on Wednesday, Cramer has a warning for investors who are salivating over the cancer immunotherapy plays.
"I need to warn you: this is a high-risk group and I have noticed a pattern that is less than ideal," Cramer said.
Bluebird is a development-stage gene therapy company that is a leading player for cancer immunotherapy. It announced positive interim phase 1 clinical trial data for its multiple myeloma therapy, which appeared to have few severe side effects, though it was a small study.
Cramer noticed that when a company like Bluebird reports good news, only the company's stock will rally. The rest of the group will barely move. But when a company reports bad news, the entire cohort gets crushed.
In the Lightning Round, Cramer gave his take on a few stocks from callers:
International Paper: "Inexpensive stock, good yield, big industrial, nice global business. I like IP, I think you buy some here and maybe buy some lower."
Berry Plastics Group: "I liked it. I can't believe how far the stock has moved. In the end, it's still just a company that makes containers. I prefer Newell, which I know has been absolutely crushed. We have been buying it for my charitable trust right here at $45."